InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Eade Katherine A., Director. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. Aggregated, 9 reports have been published. History available since 25 May 2021. The latest transaction was disclosed on 21 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
45,872 shares0Common StockSEC:0000921895-24-001305:0
25,554 shares0Common StockSEC:0000921895-23-001329:0
38,259 shares0Common StockSEC:0000921895-22-001801:0
2,525 shares0Common StockSEC:0000921895-22-000031:0
2,525 shares0Common StockSEC:0000921895-22-000031
1,401 shares0Common StockSEC:0000921895-21-002899
1,401 shares0Common StockSEC:0000921895-21-002899:0
14,400 shares0Common StockSEC:0000921895-21-001510:0
14,400 shares0Common StockSEC:0000921895-21-001510
9 of 9 declarations
About Eade Katherine A.
Katherine A. Eade is a Board Member at Harvard Bioscience Inc. She plays a key role in the governance of the company, contributing to strategic decision-making and the direction of the organization. Her experience and expertise in the life sciences sector are essential for the company's development and growth. As a board member, she actively participates in discussions regarding the company's performance and future initiatives.
